BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9488793)

  • 1. Venous thrombo-embolism and hormone replacement therapy.
    Whitehead M; Godfree V
    Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):587-99. PubMed ID: 9488793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone replacement therapy and venous thromboembolism.
    Wu O
    Gend Med; 2005; 2 Suppl A():S18-27. PubMed ID: 16551553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and venous thromboembolism.
    Eisenberger A; Westhoff C
    J Steroid Biochem Mol Biol; 2014 Jul; 142():76-82. PubMed ID: 24007716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in women with history of thrombosis or a thrombophilia.
    Morris G; Talaulikar V
    Post Reprod Health; 2023 Mar; 29(1):33-41. PubMed ID: 36573625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HRT and the risk of deep vein thrombosis.
    Barlow DH
    Int J Gynaecol Obstet; 1997 Oct; 59 Suppl 1():S29-33. PubMed ID: 9386213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of hormone replacement treatment of menopause on the risk of venous thromboembolic disease].
    Thery C; Prat A; Asseman P; Bauchart JJ; Michon P; Lesenne M; Jude B
    Therapie; 1997; 52(3):165-8. PubMed ID: 9366099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent concerns surrounding HRT.
    Armitage M; Nooney J; Evans S
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):145-55. PubMed ID: 12864790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.
    Oger E; Scarabin PY
    Drugs Aging; 1999 Jan; 14(1):55-61. PubMed ID: 10069408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy and venous thromboembolism].
    Trillot N; Susen S; Jude B
    Gynecol Obstet Fertil; 2004 Sep; 32(9):725-8. PubMed ID: 15380753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H; de Moerloose P; Campana A
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review.
    Castellsague J; Pérez Gutthann S; García Rodríguez LA
    Drug Saf; 1998 Feb; 18(2):117-23. PubMed ID: 9512918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based indications for thrombophilia screening.
    Lindhoff-Last E; Luxembourg B
    Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
    Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
    Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
    Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
    Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal thrombo-embolism: risk factors, clinical features and outcome.
    Demirel N; Aydin M; Zenciroglu A; Bas AY; Yarali N; Okumus N; Cinar G; Ipek MS
    Ann Trop Paediatr; 2009 Dec; 29(4):271-9. PubMed ID: 19941750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone replacement therapy and venous thromboembolism].
    Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
    Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future research needs for venous thrombo-embolic disease in obstetrics and gynaecology.
    Brocklehurst P
    Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):601-10. PubMed ID: 9488794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy: dilemmas in 2002.
    Moore A
    Trans Am Clin Climatol Assoc; 2003; 114():233-8; discussion 238-40. PubMed ID: 12813923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adverse effects of hormone replacement therapy.
    Tavani A; La Vecchia C
    Drugs Aging; 1999 May; 14(5):347-57. PubMed ID: 10408735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.